39 results
S-1
EX-3.3
NRIX
Nurix Therapeutics Inc
2 Jul 20
IPO registration
4:04pm
at all meetings of the stockholders and the Board of Directors. The Chairman of the Board of Directors shall perform other duties commonly incident … . The President shall perform other duties commonly incident to the office and shall also perform such other duties and have such other powers as the Board
DRS
EX-3.3
NRIX
Nurix Therapeutics Inc
5 May 20
Draft registration statement
12:00am
perform other duties commonly incident to the office and shall also perform such other duties and have such other powers as the Board of Directors … of the business and officers of the corporation. The President shall perform other duties commonly incident to the office and shall also perform such other duties
10-Q
2020 Q3
EX-3.2
NRIX
Nurix Therapeutics Inc
14 Oct 20
Quarterly report
4:02pm
than the President) and shall perform all duties and have all powers that are commonly incident to the office of President or that are delegated … and the Chief Executive Officer, the Chief Financial Officer shall perform all duties and have all powers that are commonly incident to the office of Chief
8-K
EX-3.1
NRIX
Nurix Therapeutics Inc
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
perform all duties and have all powers that are commonly incident to the office of President or that are delegated to the President by the Board … , the Chief Financial Officer shall perform all duties and have all powers that are commonly incident to the office of Chief Financial Officer
8-K
EX-1.1
pgz8n
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
S-3ASR
EX-1.2
lf71u8 prt3
4 Aug 21
Automatic shelf registration
4:11pm
DRS
EX-4.2
iu9vhwmrmg8x
5 May 20
Draft registration statement
12:00am
S-1
EX-4.2
uzb65 075wcuuf70nn
2 Jul 20
IPO registration
4:04pm
DEF 14A
gtgqjkf3i6ukt6aef
25 Mar 21
Definitive proxy
6:03am
8-K
EX-10.1
628fu
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
10-Q
ymrl z5r8nqtns8j529
14 Oct 20
Quarterly report
4:02pm